Odborné publikácie

Publikácie

Dôležitosť Glukozanímu bola skúmaná v mnohých lekárskych a výskumných štúdiách popredných výskumníkov,  ktorí sa témou osteoartrózy a  bolestivosti kĺbov už roky zaoberajú.

  1. RICHY, F., et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch Intern Med. 2003, roč. 163, čís. 13, s. 1514–1522. Dostupné online. ISSN 0003-9926.
  2. REGINSTER, J. Y., et al. Longterm progression of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial. Lancet. 2001, roč. 357, čís. 9252, s. 251–256. Dostupné online. ISSN 0140-6736.
  3. PAVELKA, K., et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002, roč. 162, čís. 18, s. 2113–2123. Dostupné online. ISSN 0003-9926.
  4. JORDAN, K. M., et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003, roč. 62, čís. 12, s. 1145–1455. Dostupné online. ISSN 0003-4967.

  1. Vaz AL. Double-blind clinical evaluation of the relative efficacy of glucosamine sulphate in the management of osteoarthritis of the knee in out-patients. Curr Med Res Opin 1982;8:145-149.
  2. Rovati LC, Giacovelli G, Annefeld M, Dreiser RL, Avouac B. A Large, Randomised, Placebo Controlled, Double-blind study of GlPucosamine Sulfate vs. Piroxicam and vs their Association, on the Kinetics of the Symptomatic Effect in Knee Osteoarthritis. Osteoarthritis Cartilage 1994;2(suppl 1):56
  3. Pavelka K: Glukosamin v léčbě osteoartrózy – fakta a mýty. Postgraduální medicína 2007;7:211-216
  4. Fernandes L, Hagen KB, Bijlsma JW,et al.; European League Against Rheumatism (EULAR). EULAR recommendations for the non-pharmacological core managementof hip and knee osteoarthritis.Ann Rheum Dis. 2013 Jul;72(7):1125-35
  5. Bartlett SJ, et al. Relationship among Weight Loss, Body Composition, and Symptom Improvement in Overweight Persons with Knee OA. ACR 2005 annual meeting abstract 1201; San Diego, CA.
  6. Vaz AL. Double-blind clinical evaluation of the relative efficacy of glucosamine sulphate in the management of osteoarthritis of the knee in out-patients. Curr Med Res Opin 1982;8:145-149.
  7. Rovati LC, Giacovelli G, Annefeld M et al. A Large, Randomised, Placebo Controlled, Double-blind study of Glucosamine Sulfate vs. Piroxicam and vs their Association, on the Kinetics of the Symptomatic Effect in Knee Osteoarthritis. Osteoarthritis Cartilage 1994;2(suppl 1):56.
  8. Tapadinhas MJ, et al.; Oral glucosamine sulfate in the management of arthrosis; report on a multi-centre open investigation in Portugal. Pharmatherapeutica 3;157-68, 1982.
  9. Reginster JY, Deroisy R,Rovati LCet al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. 2001 Jan 27;357(9252):251-6.
  10. Richy F, Bruyere O, Ethgen O et al. Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee OsteoarthritisA Comprehensive Meta- analysis. Arch Intern Med. 2003;163(13):1514-1522.
  11. Altman RD, Abadie E, Avouac B, et al. (2005) Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage 13:13-9.
  12. Capps JC, et al.; Hexosamine metabolism. II. Effect of insulin and phlorizin on the absorption and metabolism, in vivo, of D-glucosamine and N-acetyl-glucosamine in the rat. Biochim Biophys Acta 127;205-12, 1966.
  13. Towhead TE, Maxwell, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis .The Cochrane Libr/Oxford/ 2005;4:IDCD002946.